Graphite Financial Statements From 2010 to 2024
| GRPHDelisted Stock | USD 2.67 0.05 1.84% |
Check Graphite Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Graphite Bio's main balance sheet or income statement drivers, such as , as well as many indicators such as . Graphite financial statements analysis is a perfect complement when working with Graphite Bio Valuation or Volatility modules.
Graphite |
Graphite Bio Company Current Valuation Analysis
Graphite Bio's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Graphite Bio Current Valuation | 1.88 M |
Most of Graphite Bio's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Graphite Bio is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CompetitionIn accordance with the recently published financial statements, Graphite Bio has a Current Valuation of 1.88 M. This is 99.99% lower than that of the Biotechnology sector and 99.96% lower than that of the Health Care industry. The current valuation for all United States stocks is 99.99% higher than that of the company.
Graphite Bio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Graphite Bio's current stock value. Our valuation model uses many indicators to compare Graphite Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Graphite Bio competition to find correlations between indicators driving Graphite Bio's intrinsic value. More Info.Graphite Bio is rated below average in return on equity category among its peers. It is rated # 5 in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Graphite Bio's earnings, one of the primary drivers of an investment's value.About Graphite Bio Financial Statements
Investors use fundamental indicators, such as Graphite Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Graphite Bio's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. Graphite Bio, Inc. was incorporated in 2017 and is headquartered in South San Francisco, California. Graphite Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 111 people.
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Other Consideration for investing in Graphite Stock
If you are still planning to invest in Graphite Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Graphite Bio's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |